Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Alan Musso | M | 62 |
Targacept, Inc.
 Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | 12 years |
| G. Steven Burrill | M | 79 |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | 13 years |
| John P. Richard | M | 66 |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | 13 years |
| Julia Brown | F | 76 |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | - |
| Daniel Johnson | M | 79 |
University of London
| 6 years |
| James Tak Him Lee | M | 76 |
University of London
| 4 years |
| Peter A. Zorn | M | 53 |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | 10 years |
| Alan Dunton | M | 70 |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | 9 years |
| Pamela Kirby | M | 70 |
University of London
| 7 years |
| Errol de Souza | M | 70 |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | 11 years |
| Ralph Snyderman | M | 84 |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | 6 years |
| Leslie Hudson | M | 76 |
University of London
| 8 years |
| Michael Stephen Johnson | M | 74 |
University of London
| 5 years |
| Warren Cooper | M | 71 |
University of London
| 7 years |
| Michael Barrett | M | 81 |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | 11 years |
| Syed Bin Syed Salim | M | 80 |
University of London
| 1 years |
| Lin Chung Tse | M | 63 |
University of London
| 17 years |
| Ajay Sharma | M | - |
University of London
| 3 years |
| Krzysztof Sroczynski | M | 71 |
University of London
| 4 years |
| Musa bin Mohamad | M | 80 |
University of London
| 1 years |
| Peter Geffen | M | - |
University of London
| 4 years |
| Sukhinderjit Singh Muker | M | 77 |
University of London
| 3 years |
| Izlan bin Izhab | M | 78 |
University of London
| 3 years |
| Chew Peh Ting | M | 82 |
University of London
| 1 years |
| Puan Wah Wong | M | 76 |
University of London
| 4 years |
| Mark McGeough | M | - |
University of London
| 4 years |
| Iain Michael Light | M | 70 |
University of London
| 4 years |
| Sabri bin Ahmad | M | 76 |
University of London
| 1 years |
| Gerald Edward Burgon | M | - |
University of London
| 4 years |
| Duvall McClellan Williams | M | - |
University of London
| 3 years |
| Chin Man Leung | M | - |
University of London
| 4 years |
| Oghenakpobo Jonathan A. Idudu | M | - |
University of London
| 4 years |
| Martin Berry | M | - |
University of London
| 4 years |
| Scott N. Cullison | M | - |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | - |
| Farouk al-Sharaa | M | 85 |
University of London
| 4 years |
| Mohamed Apandi bin Ali | M | 74 |
University of London
| - |
| Samuel Campbell | M | - |
University of London
| 3 years |
| Panglima Richard Malanjum | M | 72 |
University of London
| 3 years |
| Steve Allen | M | - |
University of London
| 2 years |
| Salahuddin Ahmad | M | - |
University of London
| 1 years |
| Asad Munir | M | - |
University of London
| 3 years |
| Chi Leong Chan | M | 77 |
University of London
| 2 years |
| Clive Needham | M | - |
University of London
| 4 years |
| James Black | M | - |
University of London
| 4 years |
| Aishah Ong | M | 79 |
University of London
| 4 years |
| David A. Hosford | M | 68 |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | 7 years |
| Ross Henderson Paul | M | - |
University of London
| 3 years |
| Graham W. Burton | M | - |
University of London
| 3 years |
| Aditi Pant | M | - |
University of London
| 3 years |
| Benjamin Aggrey Ntim | M | - |
University of London
| 3 years |
| Donald Addington | M | - |
University of London
| 3 years |
| Yeh Kwong Lee | M | 88 |
University of London
| 3 years |
| Kweng Chong Ng | M | 76 |
University of London
| 4 years |
| Maxwell L. H. Quin | M | - |
University of London
| 3 years |
| Zik Chuka Obi | M | - |
University of London
| 3 years |
| Nigel Grace | M | - |
University of London
| 4 years |
| Yung Wei Wu | M | 72 |
University of London
| 4 years |
| Jana Whitlock | F | - |
University of London
| 4 years |
| Adrian G. Mann | M | - |
University of London
| 3 years |
| Yee Ming Eu | M | 76 |
University of London
| 3 years |
| Jeffrey P. Brennan | M | 66 |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | 10 years |
| Huw Thomas | M | 71 |
University of London
| 4 years |
| Ann Hanham | M | 71 |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | 1 years |
| Anthony J. Payne | M | - |
University of London
| 3 years |
| Ray Maxwell | M | 72 |
University of London
| 4 years |
| Stephen E. Haggerty | M | - |
University of London
| 3 years |
| Geoffrey Guy | M | 70 |
University of London
| 4 years |
| Linda J. Allison | M | 76 |
University of London
| 1 years |
| Saiyed Raza | M | 74 |
University of London
| 3 years |
| David Garman | M | 73 |
University of London
| 4 years |
| Julian Michael Horn-Smith | M | 76 |
University of London
| 4 years |
| Bruce Seton | M | - |
University of London
| 3 years |
| Rudolph Cleveland Carryl | M | - |
University of London
| 3 years |
| Christopher J. Dyball | M | 73 |
University of London
| 4 years |
| Nader Hamad Al-Sultan | M | 75 |
University of London
| 4 years |
| Roger Thomas | M | 79 |
University of London
| 4 years |
| Harvey M. J. Lawson | M | 75 |
University of London
| 4 years |
| Timothy Clark | M | - |
University of London
| 4 years |
| Charles Richard Vos | M | 79 |
University of London
| 4 years |
| Timothy J. Probert | M | 72 |
University of London
| 4 years |
| John May | M | 76 |
University of London
| 4 years |
| Graham Turner | M | - |
University of London
| 4 years |
| John Marshall | M | - |
University of London
| 3 years |
| Mustaffa bin Mohamad | M | 73 |
University of London
| 4 years |
| Tak Ching Foo | M | 90 |
University of London
| 3 years |
| Christopher Wade Sherwell | M | 76 |
University of London
| 4 years |
| Steven Heap | M | 73 |
University of London
| 4 years |
| Quek Peng Ng | M | 70 |
University of London
| 4 years |
| Shmuel Pinhas | M | 85 |
University of London
| 1 years |
| Graham Fleming | M | - |
University of London
| 3 years |
| Brian Moon | M | - |
University of London
| 4 years |
| Iqbal Jaffer Boga | M | 74 |
University of London
| 4 years |
| Mohamed Arif bin Nun | M | 78 |
University of London
| 4 years |
| Michael D. Johnson | M | 73 |
University of London
| 4 years |
| Gerald Harper | M | 79 |
University of London
| 3 years |
| Clive F. Burrett | M | 75 |
University of London
| 4 years |
| Martin Kavanagh | M | - |
University of London
| 4 years |
| Michael Creswell | M | - |
University of London
| 4 years |
| John Ho | M | 78 |
University of London
| 3 years |
| Ian Hodkinson | M | 69 |
University of London
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 87 | 87.00% |
| United States | 13 | 13.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Geoffrey C. Dunbar
- Personal Network
